Borko Jovanovic Selected Research

Borko Jovanovic Research Topics

Disease

15	Neoplasms (Cancer) 10/2021 - 11/2002
12	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 11/2002
7	Neoplasm Metastasis (Metastasis) 01/2019 - 06/2006
6	Breast Neoplasms (Breast Cancer) 01/2020 - 06/2005
4	Systemic Scleroderma (Systemic Sclerosis) 01/2021 - 03/2007
4	Disease Progression 01/2019 - 10/2003
3	Neutropenia 01/2021 - 06/2005
3	Relapsing-Remitting Multiple Sclerosis 01/2019 - 03/2009
3	Infections 03/2013 - 07/2008
3	Multiple Sclerosis 03/2007 - 10/2003
2	Glioma (Gliomas) 10/2021 - 11/2012
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 03/2007
2	Inflammation (Inflammations) 01/2020 - 11/2010
2	Renal Cell Carcinoma (Grawitz Tumor) 10/2008 - 07/2008
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2007 - 02/2006
1	Leukemia 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2021
1	Glioblastoma (Glioblastoma Multiforme) 10/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Obesity 01/2021
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 11/2020
1	Adenocarcinoma of Lung 05/2020
1	Cystic Fibrosis (Mucoviscidosis) 01/2020
1	Nausea 01/2020
1	Ulcerative Colitis 01/2020
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Neuromyelitis Optica (Devic's Disease) 10/2019
1	Central Nervous System Lupus Vasculitis 10/2019
1	Aberrant Crypt Foci 01/2018
1	Multiple Myeloma 01/2018
1	Carcinogenesis 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Circulating Neoplastic Cells 10/2016
1	Penile Neoplasms (Penile Cancer) 04/2016
1	Triple Negative Breast Neoplasms 06/2015

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 10/2021 - 12/2008
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 06/2005
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2015
3	DNA (Deoxyribonucleic Acid)IBA 10/2016 - 04/2015
3	EndoglinIBA 01/2011 - 11/2002
3	Transforming Growth Factor beta (TGF-beta)IBA 03/2010 - 07/2008
2	Transaminases (Aminotransferases)IBA 01/2020 - 11/2012
2	Hormones (Hormone)IBA 01/2020 - 06/2006
2	Prostate-Specific Antigen (Semenogelase)IBA 11/2019 - 06/2006
2	GenisteinIBA 01/2019 - 08/2009
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 04/2012
2	Neutralizing AntibodiesIBA 04/2015 - 11/2010
2	p38 Mitogen-Activated Protein KinasesIBA 01/2014 - 08/2009
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2014 - 08/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2010 - 08/2006
2	Alemtuzumab (Campath)FDA Link 03/2009 - 03/2007
2	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2006 - 06/2005
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	gilteritinibIBA 01/2022
1	GoldIBA 10/2021
1	SilverIBA 10/2021
1	Pharmaceutical PreparationsIBA 10/2021
1	Nucleic AcidsIBA 10/2021
1	fludarabineIBA 01/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 11/2020
1	BerberineIBA 01/2020
1	Mesalamine (Mesalazine)FDA LinkGeneric 01/2020
1	ivacaftorIBA 01/2020
1	telapristone acetateIBA 01/2020
1	Biological ProductsIBA 01/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2020
1	Aquaporin 4IBA 10/2019
1	Immunoglobulin G (IgG)IBA 10/2019
1	KBU2046IBA 01/2018
1	LaxativesIBA 01/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2018
1	Bortezomib (Velcade)FDA Link 01/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2017
1	Cell-Free Nucleic AcidsIBA 10/2016
1	eribulin FDA Link 06/2015
1	Carboplatin (JM8)FDA LinkGeneric 06/2015
1	Chemotactic FactorsIBA 04/2015
1	CytokinesIBA 04/2015
1	3- (4- methylphenylsulfonyl)- 2- propenenitrileIBA 04/2015
1	ChemokinesIBA 04/2015

Therapy/Procedure

10	Hematopoietic Stem Cell Transplantation 01/2021 - 10/2003
9	Therapeutics 10/2021 - 10/2003
4	Stem Cell Transplantation 10/2014 - 03/2009
3	Chemoprevention 01/2018 - 03/2004
2	Immunotherapy 12/2021 - 10/2008
2	Drug Therapy (Chemotherapy) 12/2021 - 06/2005
2	Transplantation 03/2013 - 02/2006
1	Prostatectomy (Retropubic Prostatectomy) 01/2022
1	Intravenous Administration 10/2021
1	Contraindications 01/2021
1	Operative Time 01/2021
1	Erythrocyte Transfusion 01/2021
1	Plasmapheresis 11/2020
1	Salvage Therapy 10/2019
1	Oral Administration 01/2018
1	Lymph Node Excision (Lymph Node Dissection) 04/2016
1	Neoadjuvant Therapy 06/2015